Folgen
Matthew J. Maurer, MS DMSc
Matthew J. Maurer, MS DMSc
Associate Professor of Biostatistics and Medicine, Mayo Clinic
Bestätigte E-Mail-Adresse bei mayo.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
M Crump, SS Neelapu, U Farooq, E Van Den Neste, J Kuruvilla, J Westin, ...
Blood 130 (16), 1800-1808, 2017
14522017
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study
E Galanis, JC Buckner, MJ Maurer, JI Kreisberg, K Ballman, J Boni, ...
Journal of Clinical Oncology 23 (23), 5294-5304, 2005
8502005
Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from …
C Casulo, M Byrtek, KL Dawson, X Zhou, CM Farber, CR Flowers, ...
Journal of Clinical Oncology 33 (23), 2516, 2015
7892015
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
ER Parrilla Castellar, ES Jaffe, JW Said, SH Swerdlow, RP Ketterling, ...
Blood, The Journal of the American Society of Hematology 124 (9), 1473-1480, 2014
4982014
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study
E Galanis, KA Jaeckle, MJ Maurer, JM Reid, MM Ames, JS Hardwick, ...
Journal of clinical oncology 27 (12), 2052, 2009
4242009
Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy
MJ Maurer, H Ghesquières, JP Jais, TE Witzig, C Haioun, CA Thompson, ...
Journal of Clinical Oncology 32 (10), 1066, 2014
4002014
Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III intergroup trial alliance/CALGB 50303
NL Bartlett, WH Wilson, SH Jung, ED Hsi, MJ Maurer, LD Pederson, ...
Journal of clinical oncology 37 (21), 1790, 2019
3472019
Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/Mayo Clinic Specialized Program of Research …
BK Link, MJ Maurer, GS Nowakowski, SM Ansell, WR Macon, SI Syrbu, ...
Journal of clinical oncology 31 (26), 3272, 2013
3332013
Non‐H odgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the N ational C ancer D ata B ase from 1998 to 2011
M Al‐Hamadani, TM Habermann, JR Cerhan, WR Macon, MJ Maurer, ...
American journal of hematology 90 (9), 790-795, 2015
2962015
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma
MT Drake, MJ Maurer, BK Link, TM Habermann, SM Ansell, IN Micallef, ...
Journal of clinical oncology 28 (27), 4191, 2010
2732010
The ratios of CD8+ T cells to CD4+ CD25+ FOXP3+ and FOXP3-T cells correlate with poor clinical outcome in human serous ovarian cancer
CC Preston, MJ Maurer, AL Oberg, DW Visscher, KR Kalli, LC Hartmann, ...
PloS one 8 (11), e80063, 2013
2632013
Low‐dose, single‐agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group
SM Ansell, DJ Inwards, KM Rowland Jr, PJ Flynn, RF Morton, DF Moore Jr, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
2422008
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival
PD Brown, MJ Maurer, TA Rummans, BE Pollock, KV Ballman, JA Sloan, ...
Neurosurgery 57 (3), 495-504, 2005
2402005
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
MJ Maurer, E Bachy, H Ghesquières, SM Ansell, GS Nowakowski, ...
American journal of hematology 91 (11), 1096-1101, 2016
2292016
Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders
IM Ghobrial, TM Habermann, MJ Maurer, SM Geyer, KM Ristow, ...
J Clin Oncol 23 (30), 7574-7582, 2005
2222005
Prospective study of quality of life in adults with newly diagnosed high-grade gliomas
PD Brown, KV Ballman, TA Rummans, MJ Maurer, JA Sloan, BF Boeve, ...
Journal of neuro-oncology 76, 283-291, 2006
2182006
Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer
SJ Weroha, MA Becker, S Enderica-Gonzalez, SC Harrington, AL Oberg, ...
Clinical Cancer Research 20 (5), 1288-1297, 2014
2102014
Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activation
M Gupta, JJ Han, M Stenson, M Maurer, L Wellik, G Hu, S Ziesmer, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2844-2853, 2012
1982012
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma
INM Micallef, MJ Maurer, GA Wiseman, DA Nikcevich, PJ Kurtin, ...
Blood, The Journal of the American Society of Hematology 118 (15), 4053-4061, 2011
198*2011
Cause of death in follicular lymphoma in the first decade of the rituximab era: a pooled analysis of French and US cohorts
C Sarkozy, MJ Maurer, BK Link, H Ghesquieres, E Nicolas, CA Thompson, ...
Journal of clinical oncology 37 (2), 144, 2019
1972019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20